期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血管紧张素Ⅱ受体拮抗剂和他汀类联合应用的前景 被引量：1

The prospect of the combination use of angiotensinⅡ receptor blockers and statins
下载PDF
导出
摘要 血管紧张素Ⅱ受体拮抗剂(ARBs)和他汀类为临床广泛使用的两类心血管药物。两者能否联合使用或制成复合制剂,将成为心血管药物研究领域一大新的课题。目前,有研究结果表明,两者联合应用存在广泛前景。 Angiotensin Ⅱ receptor blockers （ ARBs ） and statins are commonly used cardiovascular drugs. Their combination use has become a new topic in the research field of cardiovascular drugs. At present,many studies suggest great potential of the combination use of ARB and statins.
作者 于碧莲 赵水平
机构地区 中南大学湘雅二医院心内科
出处 《中国药理学通报》 CAS CSCD 北大核心 2005年第11期1292-1295,共4页 Chinese Pharmacological Bulletin
关键词 血管紧张素Ⅱ受体拮抗剂 他汀类 肾素-血管紧张素系统 angiotensin Ⅱ receptor blockers statins renin-angiotension system
分类号 R972 [医药卫生—药品]
  • 相关文献

参考文献32

  • 1Ferrario CM, Smith R, Levy P, Strawn W. The hypertension-lipid connection: Insights into the relation between angiotensin Ⅱ and cholesterol in atherogenesis[J]. Am J Med Sci, 2002,323(1):17-24. 被引量：1
  • 2Nickenig G, Harrison DG. The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: Part II: AT(1) receptor regulation[J]. Circulation, 2002,105(4):530-6. 被引量：1
  • 3Nickenig G,Harrison DG. The AT1-Type angiotensin receptor in oxidative stress and atherogenesis part I: Oxidative stress and atherogenesis[J]. Circulation,2002,105(3):393-6. 被引量：1
  • 4Rueckschloss U, Duerrschmidt N, Morawietz H. NADPH oxidase in endothelial cells: Impact on atherosclerosis[J]. Antioxid Redox Signal,2003,5(2):17-80. 被引量：1
  • 5Nickenig G. Should angiotensin Ⅱ receptor blockers and statins be combined[J]. Circulation, 2004,110(8):1013-20. 被引量：1
  • 6Petnehazy T, Stokes KY, Russell JM, Granger N. Angiotensin Ⅱ Type-1 receptor antagonism attenuates the inflammatory and thrombogenic responses to hypercholesterolemia in venules[J]. Hypertension, 2005,45(2):209-15. 被引量：1
  • 7Morawietz H. Beyond blood pressure endothelial protection against hypercholesterolemia by angiotensin Ⅱ Type-1 receptor blockade[J]. Hypertension, 2005,45(2):185-6. 被引量：1
  • 8Phillips MI, Kagiyama S. Angiotensin Ⅱ as a pro-inflammatory mediator[J]. Curr Opin Investig Drugs, 2002,3(4):569-77. 被引量：1
  • 9Alvarez A, Cerda-Nicolas M, Naim Abu Nabah Y et al. Direct evidence of leukocyte adhesion in arterioles by angiotensin Ⅱ[J]. Blood, 2004,104(2):402-8. 被引量：1
  • 10Oubina MP,de Las Heras N, Vazquez-Perez S et al. Valsartan improves fibrinolytic balance in atherosclerotic Rabbits[J]. J Hypertens, 2002,20(2):303-10. 被引量：1

二级参考文献16

  • 1[1]Fukuhara M, Geary RL, Diz DI et al. Angiotensin-converting enzymye expression in human carotid artery atherosclerosis. Hypertension, 2000;35(1 part 2):353～9 被引量：1
  • 2[2]Maeso R, Rodrigo E, Muoz-García R et al. Losartan reduces constrictor responses to endothelin-1 and the thrombaxane A2 analogue in aortic rings from spontaneously hypertensive rats: Role of nitric oxide. J Hypertens, 1997;15( ):1677～84 被引量：1
  • 3[3]Chowienczyk PJ, Watts GF, Cockcroft JR, Ritter JM. Impaired endothelium-dependant vasodilation of forearm resistance vessels in hypercholesterolemia. Lancet, 1992;340:1430～2 被引量：1
  • 4[4]Gibbons GH. Endothelial function as a determinant of vascular function and structure: A new therapeutic target. AM J Cardiol, 1997;79(5 A):3～8 被引量：1
  • 5[5]Griending KK, Minieri CA, Ollerenshaw JD, Alexander RW. AngiotensinⅡ stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res, 1994;74:1141～8 被引量：1
  • 6[6]Sanjay R, Sabine K, Thomas M et al. AngiotensinⅡ-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. J Clin Invest, 1996;97:1916～23 被引量：1
  • 7[7]Kranzhofer R, Schmidt J, Pfeiffer CA et al. Angiotensin induced inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol, 1999;19:1623～9 被引量：1
  • 8[8]Li DY, Zhang YC, Philips MI et al. Upregulation of endothelial receptor for oxidized low-density lipoprotein(Lox-1) in cultured human coronary artery endothelial cells by angiotensin Ⅱ typeⅠreceptor activation. Circ Res, 1999;84:1043～9 被引量：1
  • 9[9]Liao L, Harris NR, Granger DN. Oxidized low-density lipoprotein and microvascular respons to ischemia-refusion. Am J Physiol, 1996;271:2508～14 被引量：1
  • 10[10]Keidar S, Kaplan M, Aviram M. Angiotensin Ⅱ-modifyied LDL is taken up by macrophages via the scavenger receptor, leading to cellular cholesterol accumulation. Arteriosclear Thromb Vasc Biol, 1996;16:97～105 被引量：1

共引文献10

同被引文献1

引证文献1

二级引证文献12

中国药理学通报
2005年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部